NCT01566175View on ClinicalTrials.gov

Use of the Neovasc Coronary Sinus Reducer System for the Treatment of Refractory Angina Pectoris in Patients With Ngina Class 3-4 Who Are Not Candidates for Revascularization

NARecruitingINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

August 30, 2011

Primary Completion Date

December 31, 2030

Study Completion Date

December 31, 2031

Conditions

Refractory Angina

Interventions

DEVICE

Neovac coronary sinus reducer

reducer

Trial Locations (2)

64239

RECRUITING

Tel Aviv Sourasky Medical Center, Tel Aviv

Unknown

RECRUITING

Tel Aviv Medical Center, Tel Aviv

All Listed Sponsors

collaborator

Shockwave Medical, Inc.

INDUSTRY

lead

Tel-Aviv Sourasky Medical Center

OTHER_GOV

NCT01566175 - Use of the Neovasc Coronary Sinus Reducer System for the Treatment of Refractory Angina Pectoris in Patients With Ngina Class 3-4 Who Are Not Candidates for Revascularization | Biotech Hunter | Biotech Hunter